Health Care - Life Science & Diagnostic Tools: 2011 Third
Institutional Investor Research is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Health Care - Life Science & Diagnostic Tools: 2011 Third

Derik de Bruin, who debuted at No. 1 last year, when this sector first appeared in the survey, falls to third;

THIRD TEAM Derik de Bruin  UBS


Derik de Bruin, who debuted at No. 1 last year, when this sector first appeared in the survey, falls to third; but he retains a loyal following, thanks to his ability to “cut through the noise and the hype and just tell it like it is,” according to one portfolio manager. The analyst joined BofA Merrill Lynch Global Research in July from UBS, and a spokesperson for his new employer tells Institutional Investor that “legal and compliance rules prohibit him from discussing his past recommendations.”


Gift this article